AMBER Competitors and Similar CompaniesClear all
IVTech's competitors and similar companies include Afyren, Be Biopharma and Novoheart.
 Be Biopharma Be Biopharma is a bioengineering company that develops B cells as a new category of cellular medicines to treat diseases like cancer, autoimmune conditions, infectious disease, and enzyme deficiencies. |  Novoheart Novoheart is a biotechnology company that develops bioartificial human heart prototypes using a combination of stem cells and tissue engineering approaches. | |||
Founding Date | Founding Date 2014 | Founding Date 2012 | Founding Date 2020 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Massaciuccoli, IT HQ | Locations Clermont-Ferrand, FR HQ | Locations Cambridge, US HQ | Locations Vancouver, CA HQ Vancouver, CA Irvine, US |
Employees | Employees 7 | Employees 1212% increase | Employees 8814% decrease | Employees N/A |
Funding | ||||
Latest funding round | Latest funding round $ 56.4k (over 11 years ago) | Latest funding round N/A | Latest funding round $ 52m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 56.4k | Total funding raised N/A | Total funding raised $ 52m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Afyren
HQ
Clermont-Ferrand, FR
Employees
121↑ 2% increase
Afyren is an industrial biotech company.
View companyBe Biopharma
HQ
Cambridge, US
Employees
88↓ 14% decrease
Be Biopharma is a bioengineering company that develops B cells as a new category of cellular medicines to treat diseases like cancer, autoimmune conditions, infectious disease, and enzyme deficiencies.
View companyNovoheart
HQ
Vancouver, CA
Novoheart is a biotechnology company that develops bioartificial human heart prototypes using a combination of stem cells and tissue engineering approaches.
View company